Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Olema Oncology

< Previous 1 2 Next >
Olema Oncology to Present New Palazestrant Clinical Data in Combination with CDK4/6 Inhibitors at the 2023 San Antonio Breast Cancer Symposium (SABCS)
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology to Participate in Upcoming Investor Conferences in November
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of Directors
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Announces Phase 2 Monotherapy Clinical Results to be Presented at the 2023 ESMO Congress
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology KAT6 Inhibitor Compounds Demonstrate Potent Anti-Tumor Activity
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Announces Expansion of Collaboration Agreement with Novartis
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Announces New Preclinical KAT6 Inhibitor Data to be Presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology to Participate in Upcoming Investor Conferences
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Announces Combined Financing for Up to $180 Million
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology to Present at the Canaccord Genuity 43rd Annual Growth Conference
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology to Present at the 2023 Jefferies Healthcare Conference
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Reports First Quarter 2023 Financial Results and Provides Corporate Update
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Announces Upcoming Poster Presentation at the 2023 ESMO Breast Cancer Annual Congress
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology to Participate in Canaccord Genuity 2023 Horizons in Oncology Virtual Conference
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Strategic Update
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology to Present at Oppenheimer 33rd Annual Healthcare Conference
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
Olema Oncology to Participate at Upcoming Investor Conferences
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.